TRACON Pharmaceuticals (TCON)
(Delayed Data from NSDQ)
$1.81 USD
+0.02 (1.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.80 -0.01 (-0.55%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TCON 1.81 +0.02(1.12%)
Will TCON be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TCON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TCON
Tracon (TCON) Moves to Buy: Rationale Behind the Upgrade
TCON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TCON
INVO, EZGO and WISA among pre-market losers
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday